Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer

Kinzler, 1996, Lessons from hereditary colorectal cancer, Cell, 87, 159, 10.1016/S0092-8674(00)81333-1

Bonnet, 1997, Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell, Nat Med, 3, 730, 10.1038/nm0797-730

Al-Hajj, 2003, Prospective identification of tumorigenic breast cancer cells, Proc Natl Acad Sci USA, 100, 3983, 10.1073/pnas.0530291100

Li, 2007, Identification of pancreatic cancer stem cells, Cancer Res, 67, 1030, 10.1158/0008-5472.CAN-06-2030

O’Brien, 2007, A human colon cancer cell capable of initiating tumour growth in immunodeficient mice, Nature, 445, 106, 10.1038/nature05372

Ricci-Vitiani, 2007, Identification and expansion of human colon-cancer-initiating cells, Nature, 445, 111, 10.1038/nature05384

Dalerba, 2007, Phenotypic characterization of human colorectal cancer stem cells, Proc Natl Acad Sci USA, 104, 10158, 10.1073/pnas.0703478104

Du, 2008, CD44 is of functional importance for colorectal cancer stem cells, Clin Cancer Res, 14, 6751, 10.1158/1078-0432.CCR-08-1034

Takaishi, 2009, Identification of gastric cancer stem cells using the cell surface marker CD44, Stem Cells, 27, 1006, 10.1002/stem.30

Huang, 2009, Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis, Cancer Res, 69, 3382, 10.1158/0008-5472.CAN-08-4418

Shmelkov, 2008, CD133 expression is not restricted to stem cells, and both CD133+ and CD133− metastatic colon cancer cells initiate tumors, J Clin Invest, 118, 2111

Bao, 2006, Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor, Cancer Res, 66, 7843, 10.1158/0008-5472.CAN-06-1010

Al Dhaybi, 2010, Expression of CD133+ cancer stem cells in childhood malignant melanoma and its correlation with metastasis, Mod Pathol, 23, 376, 10.1038/modpathol.2009.163

Artells, 2010, Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients, Eur J Cancer, 46, 642, 10.1016/j.ejca.2009.11.003

Baba, 2009, Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells, Oncogene, 28, 209, 10.1038/onc.2008.374

Tirino, 2011, Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo, FASEB J, 25, 2022, 10.1096/fj.10-179036

Griguer, 2008, CD133 is a marker of bioenergetic stress in human glioma, PLoS ONE, 3, e3655, 10.1371/journal.pone.0003655

Bidlingmaier, 2008, The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells, J Mol Med, 86, 1025, 10.1007/s00109-008-0357-8

Futschik, 2002, Gene expression profiling of metastatic and nonmetastatic colorectal cancer cell lines, Genome Lett, 1, 26, 10.1166/gl.2002.005

Madjd, 2009, CD44+ cancer cells express higher levels of the anti-apoptotic protein Bcl-2 in breast tumours, Cancer Immun, 9, 4

Hao, 2010, CD147/EMMPRIN and CD44 are potential therapeutic targets for metastatic prostate cancer, Curr Cancer Drug Targets, 10, 287, 10.2174/156800910791190193

Huerta, 2003, Gene expression profile of metastatic colon cancer cells resistant to cisplatin-induced apoptosis, Int J Oncol, 22, 663

Kawamoto, 2010, Characteristics of CD133(+) human colon cancer SW620 cells, Cell Transplant, 19, 857, 10.3727/096368910X508988

Todaro, 2007, Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4, Cell Stem Cell, 1, 389, 10.1016/j.stem.2007.08.001

Haraguchi, 2008, CD133+CD44+ population efficiently enriches colon cancer initiating cells, Ann Surgical Oncol, 15, 2927, 10.1245/s10434-008-0074-0

Miletti-Gonzalez, 2005, The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer, Cancer Res, 65, 6660, 10.1158/0008-5472.CAN-04-3478

Wiranowska, 2006, CD44 adhesion molecule and neuro-glial proteoglycan NG2 as invasive markers of glioma, Brain Cell Biol, 35, 159, 10.1007/s11068-007-9009-0

Kojima, 2008, Immunohistochemical detection of CD133 expression in colorectal cancer: a clinicopathological study, Cancer Sci, 99, 1578, 10.1111/j.1349-7006.2008.00849.x

Bendardaf, 2006, Comparison of CD44 expression in primary tumours and metastases of colorectal cancer, Oncol Rep, 16, 741

Huh, 2009, Expression of standard CD44 in human colorectal carcinoma: association with prognosis, Pathol Int, 59, 241, 10.1111/j.1440-1827.2009.02357.x

Liu, 2011, The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44, Nat Med, 17, 211, 10.1038/nm.2284

Gao, 1997, CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13, Cancer Res, 57, 846

Abetamann, 1996, Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells, Clin Cancer Res, 2, 1607